AstraZeneca PLC AZN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
76.68quote price arrow down-0.22 (-0.29%)
Volume
120,087,731
Close
76.90quote price arrow down-0.14 (-0.18%)
Volume
2,791,645
52 week range
60.47 - 77.93
Loading...
  • Open76.87
  • Day High77.07
  • Day Low76.61
  • Prev Close77.04
  • 52 Week High77.93
  • 52 Week High Date05/10/24
  • 52 Week Low60.47
  • 52 Week Low Date02/12/24

Key Stats

  • Market Cap238.426B
  • Shares Out3.10B
  • 10 Day Average Volume0.00M
  • Dividend1.45
  • Dividend Yield1.89%
  • Beta0.49
  • YTD % Change14.18

KEY STATS

  • Open76.87
  • Day High77.07
  • Day Low76.61
  • Prev Close77.04
  • 52 Week High77.93
  • 52 Week High Date05/10/24
  • 52 Week Low60.47
  • 52 Week Low Date02/12/24
  • Market Cap238.426B
  • Shares Out3.10B
  • 10 Day Average Volume0.00M
  • Dividend1.45
  • Dividend Yield1.89%
  • Beta0.49
  • YTD % Change14.18

RATIOS/PROFITABILITY

  • EPS (TTM)2.03
  • P/E (TTM)37.93
  • Fwd P/E (NTM)14.45
  • EBITDA (TTM)13.775B
  • ROE (TTM)17.29%
  • Revenue (TTM)47.611B
  • Gross Margin (TTM)82.17%
  • Net Margin (TTM)13.31%
  • Debt To Equity (MRQ)92.27%

EVENTS

  • Earnings Date07/25/2024(est)
  • Ex Div Date02/22/2024
  • Div Amount0.985
  • Split Date-
  • Split Factor-

Profile

MORE
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and includes the Alexion Rare Disease portfolio comprising approximately 178 projects....
Michel Demare
Non-Executive Independent Chairman of the Board
Pascal Soriot
Chief Executive Officer, Executive Director
Aradhana Sarin M.D.
Chief Financial Officer, Executive Director
Ruud Dobber Ph.D.
Executive Vice President - BioPharmaceuticals Business Unit
Susan Galbraith
Executive Vice President - Oncology and Research and Development
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
NVS
Novartis AG
102.57-0.12-0.12%
ABBV
AbbVie Inc
166.42+2.07+1.26%
PFE
Pfizer Inc
28.64-0.28-0.97%
RHHBY
Roche Holding AG
32.81+0.16+0.49%
AMGN
Amgen Inc
312.47-2.25-0.71%